Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding D Pharm LTD is 'Not Rated'. Macroaxis provides D Pharm buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding D Pharm positions. The advice algorithm takes into account all of D Pharm LTD available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from D Pharm buy-and-hold prospective. Additionally see Investing Opportunities.
For the selected time horizon D Pharm LTD has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0Macroaxis provides buy, hold, or sell suggestion on D Pharm LTD to complement and cross-verify current analyst consensus on D Pharm LTD. Our buy, hold, or sell recommendation engine determines the company potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure D Pharm is not overpriced, please confirm all D Pharm LTD fundamentals including its Revenue, EBITDA, Cash and Equivalents, as well as the relationship between Gross Profit and Net Income .
D Pharm Trading Alerts and Improvement Suggestions
|D Pharm LTD is not yet fully synchronised with the market data|
|The company reported revenue of 723K. Net Loss for the year was (814K) with profit before overhead, payroll, taxes, and interest of 723K.|
|D-PHARM has accumulated about 314K in cash with (313K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.|